000098420 001__ 98420
000098420 005__ 20210128133202.0
000098420 0248_ $$2sideral$$a122182
000098420 037__ $$aART-2019-122182
000098420 041__ $$aeng
000098420 100__ $$aBrenaut, E.
000098420 245__ $$aThe self-assessed psychological comorbidities of prurigo in Europe: data from the ESDAP study
000098420 260__ $$c2019
000098420 5060_ $$aAccess copy available to the general public$$fUnrestricted
000098420 5203_ $$aPS16
Prurigo is defined by the presence of chronic pruritus and multiple localized or generalized pruriginous lesions. The aim of this study was to assess the psychological burden of prurigo in patients of European countries. In this multicentre European study, 3, 635 general dermatology outpatients and 1, 359 controls were included. Socio-demographic data and answers to questionnaires (regarding quality of life, general health, anxiety and depression and suicidal ideation) were collected.There were 27 patients with prurigo; of these, 63% were men, and the mean age was 58.6 years. Among patients with prurigo, 10 of 27 (37%) suffered from anxiety and 8 of 27 (29%) from depression. Suicidal ideation was reported in 5 of 27 (19%) patients, and for 4 of these 5 patients, suicidal ideation was related to their skin disease. These frequencies were higher in the 10 commonest dermatological diseases (including psoriasis, atopic dermatitis and leg ulcers). The impact on quality of life was severe, with a mean Dermatologic Life Quality Index (DLQI) of 12.4, with an extreme impact on quality of life for 23% of patients and a very large impact for 27% of patients.The psychological comorbidities of prurigo are common, greater than those of other skin diseases, and their impact on quality of life is significant. Thus, it is important to study this condition and to find new treatments.
000098420 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000098420 590__ $$a4.016$$b2019
000098420 591__ $$aDERMATOLOGY$$b7 / 68 = 0.103$$c2019$$dQ1$$eT1
000098420 592__ $$a1.01$$b2019
000098420 593__ $$aMedicine (miscellaneous)$$c2019$$dQ1
000098420 593__ $$aDermatology$$c2019$$dQ1
000098420 655_4 $$ainfo:eu-repo/semantics/conferenceObject$$vinfo:eu-repo/semantics/publishedVersion
000098420 700__ $$aHalvorsen, J.A.
000098420 700__ $$aDalgard, F.
000098420 700__ $$aLien, L.
000098420 700__ $$aBalieva, F.
000098420 700__ $$aSampogna, F.
000098420 700__ $$aLinder, D.
000098420 700__ $$aEvers, A.
000098420 700__ $$aJemec, G.
000098420 700__ $$aGieler, U.
000098420 700__ $$aSzepietowski, J.
000098420 700__ $$aPoot, F.
000098420 700__ $$aAltunay, I.
000098420 700__ $$aFinlay, A.
000098420 700__ $$aSalek, S.
000098420 700__ $$aSzabo, C.
000098420 700__ $$aLvov, A.
000098420 700__ $$0(orcid)0000-0001-5632-0351$$aMarron, S.
000098420 700__ $$0(orcid)0000-0003-1917-6906$$aTomas Aragones, L.$$uUniversidad de Zaragoza
000098420 700__ $$aKupfer, J.
000098420 700__ $$aMisery, L.
000098420 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000098420 773__ $$g99, 8 (2019), 742$$pActa derm.-venereol.$$tACTA DERMATO-VENEREOLOGICA$$x0001-5555
000098420 85641 $$uhttps://www.medicaljournals.se/acta/download/10.2340/00015555-3228/$$zTexto completo de la revista
000098420 8564_ $$s119595$$uhttps://zaguan.unizar.es/record/98420/files/texto_completo.pdf$$yVersión publicada
000098420 8564_ $$s4352906$$uhttps://zaguan.unizar.es/record/98420/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000098420 909CO $$ooai:zaguan.unizar.es:98420$$particulos$$pdriver
000098420 951__ $$a2021-01-28-12:42:26
000098420 980__ $$aARTICLE